| 000 | 05626cam a2200385Ii 4500 | ||
|---|---|---|---|
| 001 | 95378 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112701.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170214s2017 sz o 000 0 eng d | ||
| 020 |
_a331940010X _q(electronic bk.) |
||
| 020 |
_a9783319400105 _q(electronic bk.) |
||
| 020 |
_z9783319400082 _q(print) |
||
| 035 | _a(OCoLC)972478006 | ||
| 040 |
_aN$T _cN$T _dIDEBK _dEBLCP _dGW5XE _dN$T _dYDX _dOCLCF _dUAB _dCOO _dIOG _dMERER _dESU _dZ5A _dOCLCQ _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dU3W _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRC669 _b2017 EB |
|
| 245 | 0 | 0 |
_aIntegrative cardiology : _ba new therapeutic vision _cMassimo Fioranelli, editor. |
| 264 | 1 |
_aSwitzerland _bSpringer International Publishing _c2017 |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _aForeword; Foreword; Contents; Part I: The Basis of Integration; 1: Herbal Medicine in Cardiology; 1.1 Primary Cardiological Herbs; 1.2 Metabolic Herbs; 1.3 Nervous Sedation and Neurovegetative Herbs; 1.4 Allium sativum (Garlic); 1.5 Arnica montana; 1.6 Astragalus membranaceus; 1.7 Berberine; 1.8 Camelia sinensis (Green Tea); 1.9 Commiphora mukul (Guggul); 1.10 Convallaria majalis (Lily of the Valley); 1.11 Crataegus oxyacantha (Hawthorn); 1.12 Cytisus scoparius (Broom); 1.13 Digitalis purpurea; 1.14 Gelsemium sempervirens (Yellow Jasmine); 1.15 Ginkgo biloba. | |
| 505 | 8 | _a1.16 Hibiscus sabdariffa (Roselle)1.17 Leonorus cardiaca (Motherwort); 1.18 Lycopus virginicus/europeus; 1.19 Nattokinase (Fermented Soybeans); 1.20 Plectranthus barbatus (Forskolin); 1.21 Rauvolfia serpentina (Indian Snakeroot); 1.22 Ruscus aculeatus (Butcherś Broom); 1.23 Salvia miltiorrhiza (Danshen); 1.24 Scilla maritima; 1.25 Strophantus kombe; 1.26 Terminalia arjuna; 1.27 Viscum album (Mistletoe); References; 2: Homeopathy and Cardiovascular Disease; 2.1 Historical Background and Basic Concepts; 2.2 Regional Homeopathic Remedies for the Heart; 2.2.1 Aconitum napellus. | |
| 505 | 8 | _a2.2.2 Adonis vernalis2.2.3 Apocinum cannabinum Injeel; 2.2.4 Arnica montana; 2.2.5 Arsenicum album; 2.2.6 Aurum metallicum; 2.2.7 Baryta carbonica; 2.2.8 Cactus grandiflorus; 2.2.9 Carbo vegetabilis Injeel; 2.2.10 Chininum arsenicosum; 2.2.11 Coffea cruda; 2.2.12 Digitalis purpurea; 2.2.13 Gelsemium sempervirens; 2.2.14 Glonoine; 2.2.15 Grindelia robusta; 2.2.16 Kali carbonicum; 2.2.17 Kalmia latifolia; 2.2.18 Iberis amara; 2.2.19 Lachesis mutus; 2.2.20 Latrodectus mactans; 2.2.21 Naja tripudians; 2.2.22 Prunus spinosa Injeel; 2.2.23 Spigelia marilandica; 2.2.24 Sumbul; 2.2.25 Tabacum. | |
| 505 | 8 | _a2.2.26 Veratrum albumReferences; 3: Low-Dose Therapy for the Treatment of Low-Grade Chronic Inflammation; 3.1 Introduction; 3.2 Gastrointestinal Homeostasis, Microbiota Composition and Low-Grade Chronic Inflammation; 3.3 Cardiovascular Risk Factors and Low-Grade Chronic Inflammation; 3.4 The Prognostic Role of IL-6 in LGCI and Related Cardiovascular and Kidney Diseases; 3.5 LGCI, Gut-Liver Axis and PNEI Homeostasis Breakdown; 3.6 The Cellular Target of LGCI: Impaired Mitochondrial Activity and Reflexes in Cardiovascular Dysfunction; 3.7 Low-Dose Therapy for the Treatment of LGCI. | |
| 505 | 8 | _a3.8 Low-Dose Therapy for the Enhancement of Mitochondrial FunctionsReferences; 4: Acupuncture in Cardiovascular Diseases; 4.1 Historical Background, the Beginning and the Diffusion; 4.2 Acupuncture in Cardiovascular Diseases; 4.2.1 Introduction; 4.2.2 Physiology and Pathology; 4.2.3 Cardiovascular Pathological Conditions: Evidence; 4.3 Hypertension; 4.3.1 Hypertension in TCM; 4.3.2 Acupuncture; 4.4 Myocardial Infarction and Coronary Heart Disease; 4.4.1 Coronary Heart Disease in TCM; 4.4.2 Acupuncture; 4.5 Rhythm Disorders; 4.5.1 Arrhythmias in TCM; 4.5.2 Acupuncture; 4.6 Conclusion. | |
| 520 | 3 | _aThis book is a detailed guide to a new integrative approach to the prevention and treatment of various cardiac disorders and risk factors, including coronary artery disease, congestive heart failure, arrhythmias, dyslipidemia, and hypertension. This approach combines various strategies, including metabolic cardiology, low-dose medicine, exercise programs, stress management programs, evaluation for inherited risk factors, and various other healing modalities. Metabolic cardiology focuses on the prevention, management, and treatment of cardiovascular disease at the cellular level through biochemical interventions with nutritional supplements that can promote energy production in the heart. Low-dose medicine, on the other hand, interprets pathological phenomena as an imbalance in intercellular signaling that may be corrected through the administration of low physiological doses of messenger molecules. Therapies outside of mainstream medicine may also be deployed in integrative cardiology, for example acupuncture, herbal medicine, and homeopathy. Integrative Cardiology will be of interest to all practitioners wishing to learn about an approach that incorporates the incredible advances in medication and technology with a focus on nutrition, lifestyle, and mind?body influences. | |
| 650 | 7 |
_9138557 _aCardiología _2fast _0(OCoLC)fst00847121 _0 |
|
| 700 | 1 |
_aFioranelli, Massimo, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-40010-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aSpringer_Medicine_2017 | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c95378 _d95378 _x1 |
||